XML 81 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:      
Net income $ 350,224 $ 272,171 $ 271,674
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 117,510 70,599 43,597
Amortization of debt issuance costs and bond premium, net 4,184 3,625 2,363
Amortization of deferred items 1,040 (4,337) 3,333
Provision for doubtful accounts 3,871 0 0
Provision for inventory obsolescence 1,711 765 735
Deferred income tax benefit (816) (989) (1,065)
Share-based compensation expense 14,231 10,402 6,314
Other, net 977 457 4,847
Change in assets and liabilities:      
Accounts receivable (36,330) (80,013) 13,214
Income tax receivable 1,078 (119) 10,421
Inventory (43,254) (23,395) (6,249)
Prepaid expenses (712) (6,386) 845
Deferred costs and other assets (19,706) (32,597) (10,379)
Accounts payable 11,440 27,536 (1,173)
Accrued liabilities 1,430 (7,096) 4,440
Bond premium 8,500 0 0
Income tax payable 5,863 1,250 (17,906)
Deferred credits and other liabilities 10,869 23,730 14,777
Net cash provided by operating activities 432,110 255,603 339,788
Cash flows from investing activities:      
Capital expenditures (745,223) (785,083) (514,858)
Proceeds from sale of assets 147 7,646 218
Net cash used by investing activities (745,076) (777,437) (514,640)
Cash flows from financing activities:      
Proceeds from issuance of bonds 200,000 450,000 0
Proceeds from bank credit facilities 400,000 310,000 345,000
Principal payments on bank credit facilities (175,000) (450,000) (55,000)
Proceeds from notes payable 14,095 5,148 9,092
Principal payments on notes payable (11,172) (5,461) (3,631)
Repurchase and retirement of common shares (107,260) 0 0
Proceeds from exercise of stock options 9,224 5,546 6,192
Debt issuance costs paid (6,022) (10,530) (12,322)
Net cash provided by financing activities 323,865 304,703 289,331
Net increase (decrease) in cash and cash equivalents 10,899 (217,131) 114,479
Cash and cash equivalents, at beginning of period 77,871 295,002 180,523
Cash and cash equivalents, at end of period $ 88,770 $ 77,871 $ 295,002